The CEACAM6 “high” group of patients showed a trend towards poorer overall survival (Figure 3E ).
← all excerpts
CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer.
1
—
—
The CEACAM6 “high” group of patients showed a trend towards poorer overall survival (Figure 3E ).